menu search

Agios pharmaceuticals: positive phase 2 results in sickle cell study

Agios Pharmaceuticals is a biotech company focused on developing medicines for cancer and rare genetic diseases. The company's financials show growth,...

August 17, 2023, 5:14 am

Agios unveils 2023-2026 value-driving catalysts enabling company’s vision to transform patient outcomes in rare diseases

– Consistent and compelling clinical data across rare hematological diseases support five ongoing pivotal trials in thalassemia, sickle cell disease...

January 9, 2023, 1:00 am


Search within

Pages Search Results: